Site Search
Professionals 294 results
Capabilities 68 results
Practice Area
Product Liability & Mass Torts
Major multinational companies trust Winston to defend their products and reputations in high-profile, high-stakes product liability and mass tort claims. Our Product Liability & Mass Torts Practice is one of the industry’s most seasoned, with a deep bench of experienced lawyers and a unique combination of extensive trial experience and expansive technical knowledge.
Industry
Energy Industry Litigation & Investigations
With our reputation as a trial lawyers’ firm serving as our foundation, we advocate for a variety of power producers, oil and gas companies, and oilfield services providers in high-stakes litigation throughout U.S. district and appellate courts. We also handle sensitive investigations, contentious regulatory and enforcement issues, and arbitration. Our bench is stacked with innovative legal and commercial problem solvers, many of whom came to Winston from in-house positions, amplifying their appreciation for C-suite complexities. By combining our knowledge of the energy industry with first-rate trial skills, and the experience our practitioners have gained from learning our clients’ businesses, we are positioned to obtain the best result for our clients efficiently—whether in the courtroom or a negotiated solution.
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Health Care & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions.
Experience 44 results
Experience
|September 25, 2024
Winston represents the founding partners of EDL in a new LBO
Experience
|July 17, 2024
Winston advises Downtown Paris on its acquisition by Publicis Groupe
Experience
|June 6, 2024
Winston Represented Shore Capital Partners in its Sale of Behavioral Innovations
Insights & News 1,239 results
Speaking Engagement
|November 8, 2024
Keerthika Subramanian Discusses Equity Rights Offerings for Distressed Issuers Outside Chapter 11
Winston & Strawn partner Keerthika Subramanian will be leading a session for the Practising Law Institute program on liability management, focusing on equity rights offerings as an alternative for distressed companies. As many pandemic-era debt issuances are nearing maturity, companies face challenges due to the high cost of capital and market volatility. This session will explore how equity rights offerings, traditionally used in Chapter 11 bankruptcies and by foreign issuers, are becoming a viable option for domestic issuers outside of bankruptcy.
Seminar/CLE
|October 23, 2024
Winston’s Product & Mass Torts Summit Series 2024
Winston’s Product Liability & Mass Torts Practice Group is pleased to invite you to the second in a series of panels to be presented in key U.S. markets through our Product & Mass Tort Summit. This one-hour CLE panel will bring together Winston partners with in-house counsel Alex Dimitrief (Sotera Health) and Michael Del Negro (Peloton) to dig into practical and actionable considerations for corporate counsel in managing product liability and mass tort cases, including:
Sponsorship
|October 16, 2024
Winston & Strawn Sponsors ChIPs 2024 Global Summit
Winston & Strawn is proud to sponsor and attend the 2024 ChIPs Global Summit, which draws women from all over the world working in technology, policy, private practice, corporations, government, academia, and beyond. Each year, the summit aims to advance innovation through diversity of thought and connect women through engagement opportunities. This year’s summit will be held October 16-18 in Washington, D.C., and includes U.S. Supreme Court Justice Ketanji Brown Jackson as a speaker.
Other Results 43 results
Site Content
Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through submission of an abbreviated Biologics License Application (aBLA).
Site Content
In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff.
Law Glossary
A safe harbor is a legal provision in a statute or regulation that provides protection from a legal liability or other penalty when certain conditions are met.